Publication:
Rituximab Used in Three Cases with Relapsed Non-Hodgkin's Lymphoma

Simple item page
dc.authorwosidAydin, Ramazan/C-2550-2014
dc.authorwosidYilmaz, Sema/Aaa-3115-2020
dc.contributor.authorElli, Murat
dc.contributor.authorYilmaz, Sema
dc.contributor.authorAydin, Ramazan
dc.contributor.authorMurat, Sadriye
dc.contributor.authorBilgici, Meltem Ceyhan
dc.contributor.authorDagdemir, Ayhan
dc.date.accessioned2025-12-11T00:46:04Z
dc.date.issued2013
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Elli, Murat; Yilmaz, Sema; Dagdemir, Ayhan] Ondokuz Mayis Univ, Fac Med, Dept Pediat Hematol Oncol, TR-55220 Samsun, Turkey; [Aydin, Ramazan; Bilgici, Meltem Ceyhan] Ondokuz Mayis Univ, Fac Med, Dept Radiol, TR-55220 Samsun, Turkey; [Aydin, Ramazan] Ondokuz Mayis Univ, Fac Med, Dept Pediat, TR-55220 Samsun, Turkeyen_US
dc.description.abstractRelapsed or refractory B-cell non-Hodgkin's lymphoma (B-NHL) patients have a poor prognosis. New treatment modalities have been used to improve survival rates in children with relapsed or refractory B-NHL. CD20 is expressed in >98% of childhood B-NHL and a chimeric anti-CD20 monoclonal antibody, rituximab, is increasingly being used at relapse. The aim of the present study was to determine the efficacy of rituximab on relapsed B-NHL. Three B-NHL cases were treated successfully with a combination of intensive chemotherapy protocol plus rituximab.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.doi10.3892/mco.2013.88
dc.identifier.endpage552en_US
dc.identifier.issn2049-9450
dc.identifier.issn2049-9469
dc.identifier.issue3en_US
dc.identifier.pmid24649209
dc.identifier.scopusqualityQ4
dc.identifier.startpage550en_US
dc.identifier.urihttps://doi.org/10.3892/mco.2013.88
dc.identifier.urihttps://hdl.handle.net/20.500.12712/39040
dc.identifier.volume1en_US
dc.identifier.wosWOS:000453139300027
dc.language.isoenen_US
dc.publisherSpandidos Publ Ltden_US
dc.relation.ispartofMolecular and Clinical Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRituximaben_US
dc.subjectNon-Hodgkin's Lymphomaen_US
dc.subjectRelapseen_US
dc.subjectChildrenen_US
dc.titleRituximab Used in Three Cases with Relapsed Non-Hodgkin's Lymphomaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu